Factors associated with difficulty achieving initial control with Crotalidae polyvalent immune fab antivenom in snakebite patients

Academic Emergency Medicine

Volumn 18, Issue 1, 2011, Pages 46-52

  Yin, Shan ^a   Kokko, Jamie ^a   Lavonas, Eric ^a   Mlynarchek, Sara ^a   Bogdan, Greg ^a   Schaeffer, Tammi ^a  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; POLYCLONAL ANTIBODY; SNAKE VENOM; SNAKE VENOM ANTISERUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; DRUG EFFICACY; ENVENOMATION; FEMALE; HOSPITAL PHARMACY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROLOGICAL COMPLICATION; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SNAKEBITE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVENINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SNAKE BITES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 78651365614     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2010.00958.x     Document Type: Article

References (21)

1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL,. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila). 2009; 47: 911-1084.
2. Gold BS, Dart RC, Barish RA,. Bites of venomous snakes. N Engl J Med. 2002; 347: 347-56.
3. Protherics Inc,. CroFab Prescribing Information. Brentwood, TN: Protherics Inc., 2006.
4. Offerman SR, Barry JD, Schneir A, Clark RF,. Biphasic rattlesnake venom-induced thrombocytopenia. J Emerg Med. 2003; 24: 289-93.
5. Camilleri C, Offerman S, Gosselin R, Albertson T,. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation. Clin Toxicol (Phila). 2005; 43: 201-6.
6. Gold BS, Barish RA, Rudman MS,. Refractory thrombocytopenia despite treatment for rattlesnake envenomation. N Engl J Med. 2004; 350: 1912-3.
7. Fazelat J, Teperman SH, Touger M,. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine). Clin Toxicol (Phila). 2008; 46: 823-6.
8. Odeleye AA, Presley AE, Passwater ME, Mintz PD,. Report of two cases: rattlesnake venom-induced thrombocytopenia. Ann Clin Lab Sci. 2004; 34: 467-70.
9. Richardson WH, Goto CS, Gutglass DJ, Williams SR, Clark RF,. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom. Clin Toxicol (Phila). 2007; 45: 472-5.
10. Dart RC, Hurlbut KM, Garcia R, Boren J,. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996; 27: 321-6.
11. Seifert SA, Boyer LV, Benson BE, Rogers JJ,. AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005. Clin Toxicol (Phila). 2009; 47: 327-35.
12. Boyer LV, Seifert SA, Clark RF, et al., Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med. 1999; 159: 706-10.
13. O'Brien NF, DeMott MC, Suchard JR, Clark RF, Peterson BM,. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation. Pediatr Emerg Care. 2009; 25: 457-9.
14. Kitchens C, Eskin T,. Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol. 2008; 4: 180-3.
15. Bond RG, Burkhart KK,. Thrombocytopenia following timber rattlesnake envenomation. Ann Emerg Med. 1997; 30: 40-4.
16. Schmaier AH, Claypool W, Colman RW,. Crotalocytin: recognition and purification of a timber rattlesnake platelet aggregating protein. Blood. 1980; 56: 1013-9.
17. Schmaier AH, Colman RW,. Crotalocytin: characterization of the timber rattlesnake platelet activating protein. Blood. 1980; 56: 1020-8.
18. Consroe P, Egen NB, Russell FE, et al., Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg. 1995; 53: 507-10.
19. Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD,. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002; 40: 619-24.
20. Isbister GK,. Antivenom efficacy or effectiveness: the Australian experience. Toxicology. 2009; 268: 148-54.
21. Chippaux JP, Williams V, White J,. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991; 29: 1279-303.